Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 665531307 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
| Invesco Ltd. 13G/A Amendment 1 | 6.3% |
8/13/2026
Event 6/30/2026
|
|
| State Street Corp 13G | 6.8% |
8/7/2026
Event 6/30/2026
|
|
|
FMR LLC
13G/A
Amendment 8
|
1.8% |
6/5/2026
Event 5/29/2026
|
|
| FMR LLC | 1.8% | ||
| Abigail P. Johnson | 1.8% | ||
| Vanguard Capital Management LLC 13G | 5.0% |
4/30/2026
Event 3/31/2026
|
|
| Vanguard Portfolio Management LLC 13G | 6.3% |
4/29/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 1 | 0% |
3/27/2026
Event 3/13/2026
|
|
| Invesco Ltd. 13G | 5.1% |
2/12/2026
Event 12/31/2025
|
|
|
FMR LLC
13G/A
Amendment 7
|
7.1% |
2/5/2026
Event 12/31/2025
|
|
| FMR LLC | 7.1% | ||
| Abigail P. Johnson | 7.1% | ||
| Dimensional Fund Advisors LP 13G/A Amendment 1 | 4.3% |
1/21/2026
Event 12/31/2025
|
|
| State Street Corp 13G | 5.3% |
11/10/2025
Event 9/30/2025
|
|
| Dimensional Fund Advisors LP 13G | 5.1% |
10/9/2025
Event 9/30/2025
|
|
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
8.1% |
8/14/2025
Event 6/30/2025
|
|
| American Century Investment Management, Inc. | 8.1% | ||
| American Century Companies, Inc. | 8.1% | ||
| Stowers Institute for Medical Research | 8.1% | ||
| State Street Corp 13G | 4.8% |
8/11/2025
Event 6/30/2025
|
|
| BlackRock, Inc. 13G/A Amendment 1 | 14.1% |
7/17/2025
Event 6/30/2025
|
|
| State Street Corp 13G | 5.4% |
5/13/2025
Event 3/31/2025
|
|
| State Street Corp 13G |
5.0%
Checked 5% or less
|
2/5/2025
Event 12/31/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 19 | 158 k | $3.68 M |
| 2026 Q2 | 362 | 111 M | $2.11 B |
| 2026 Q1 | 383 | 113 M | $3.29 B |
| 2025 Q4 | 344 | 108 M | $2.32 B |
| 2025 Q3 | 389 | 114 M | $2.82 B |
| 2025 Q2 | 415 | 114 M | $3.24 B |
| 2025 Q1 | 397 | 114 M | $3.44 B |
| 2024 Q4 | 423 | 111 M | $4.13 B |
| 2024 Q3 | 371 | 110 M | $3.91 B |
| 2024 Q2 | 368 | 108 M | $4.02 B |
| 2024 Q1 | 367 | 106 M | $4.20 B |
| 2023 Q4 | 362 | 104 M | $3.86 B |
| 2023 Q3 | 351 | 91.1 M | $3.67 B |
| 2023 Q2 | 322 | 90.7 M | $3.11 B |
| 2023 Q1 | 283 | 84.7 M | $2.57 B |
| 2022 Q4 | 298 | 79.0 M | $2.44 B |
| 2022 Q3 | 257 | 61.9 M | $1.70 B |
| 2022 Q2 | 249 | 61.0 M | $1.55 B |
| 2022 Q1 | 242 | 59.6 M | $1.68 B |
| 2021 Q4 | 205 | 57.9 M | $1.19 B |
| 2021 Q3 | 165 | 44.2 M | $946 M |
| 2021 Q2 | 160 | 42.5 M | $884 M |
| 2021 Q1 | 124 | 31.2 M | $377 M |
| 2020 Q4 | 95 | 17.5 M | $153 M |
| 2020 Q3 | 87 | 17.6 M | $101 M |
| 2020 Q2 | 1 | 870 | $18.0 k |
| 2020 Q1 | 1 | 870 | $18.0 k |
| 2019 Q4 | 1 | 870 | $18.0 k |
| 2019 Q3 | 1 | 870 | $18.0 k |
| 2019 Q2 | 1 | 870 | $18.0 k |
| 2019 Q1 | 2 | 1.58 k | $20.0 k |
| 2018 Q4 | 1 | 419 | $947.00 |
| 2016 Q3 | 1 | 1.20 k | $3.20 k |
| 2016 Q2 | 1 | 1.20 k | $5.52 k |
| 2016 Q1 | 2 | 1.27 k | $5.06 k |
| 2015 Q4 | 1 | 72.0 | $278.00 |
| 2015 Q3 | 1 | 72.0 | $318.00 |
| 2015 Q2 | 1 | 72.0 | $487.00 |